Is Hydroxyapatite Toothpaste Safe? Nano-HAp, FDA and ADA Explained

Last updated: September 2026  |  By: VerdictLab Editorial Team

Three different questions get blurred into one when people search “is hydroxyapatite toothpaste safe.” The EU’s scientific committee has assessed the material’s safety. The FDA has a different regulatory framework that doesn’t include HAp as an approved anticaries agent. The ADA has a voluntary Seal program that no HAp-only toothpaste has obtained. These are three separate bodies answering three separate questions — and the answer to each one is different.

This guide separates them, explains what each assessment covers and doesn’t cover, and identifies the groups where the safety evidence is thinner than marketing implies.

The Practical Safety Question Depends on the Formula and User

“Is it safe?” is the wrong question without specifying safe for whom, in what form, at what concentration, and for what use. A 10% nano-HAp toothpaste used by a healthy adult twice daily is a different safety question from a toddler swallowing a mouthful, or a pregnant woman using an untested formulation, or a product with an undisclosed particle type at an unknown concentration.

The safety assessments that exist are specific. They evaluate defined materials under defined conditions. Extending their conclusions beyond those conditions — “the EU says it’s safe, so every HAp toothpaste is safe for everyone” — is the mistake most marketing and many blog posts make.

What Human Toothpaste Studies Report About Tolerability

The clinical trials of HAp toothpaste (notably Paszynska et al. 2023 in adults and 2021 in children) did not report significant adverse events attributable to the HAp formulation during the study periods. Participants used the toothpaste twice daily for 18 months (adults) and 12 months (children) under supervised conditions.

This is a positive signal within its scope. Two caveats apply:

First, these trials were designed to measure cavity prevention, not to comprehensively capture adverse events with the statistical power of a dedicated safety trial. “No significant adverse events reported” in a 189-person trial is not the same as “proven safe in all populations” — it means nothing alarming emerged in this study, in this population, over this period.

Second, the tested formulation was specific (a particular HAp concentration, particle type, and supporting formula). A different retail product with different particle characteristics, concentration, or additional ingredients may have a different tolerability profile. The trial data applies to what was tested, not to the entire product category.

As explained in VerdictLab’s clinical evidence review, these trials can describe the adverse events reported during their study periods, but they are not large or long enough to establish rare or long-term safety across all users.

The EU SCCS Assessment: What It Covers

The European Commission’s Scientific Committee on Consumer Safety (SCCS) issued its Submission IV final opinion on June 26, 2025 (published July 1, 2025). It is the most comprehensive safety assessment of nano-hydroxyapatite in oral care products currently available from any regulatory body.

The headline finding: the SCCS considers hydroxyapatite (nano) safe when used at concentrations up to 29.5% in toothpaste and up to 10% in mouthwash.

The supporting evidence: the committee found that nano-HAp does not pose a mutagenic hazard, cytotoxicity, or inflammatory effects even at high test concentrations in a buccal mucosa cell model. Any uptake by buccal mucosa is considered negligible. Unintentionally ingested nanoparticles undergo rapid dissolution in gastric fluid and “do not raise any nano-specific concern over safety.”

Specified particles and exposures, not blanket approval

The SCCS opinion applies only to hydroxyapatite (nano) with specific characteristics:

The particles must be rod-shaped, with at least 87% (by number) having aspect ratios of 3 or less and the remaining 13% not exceeding aspect ratios of 9. The particles must not be coated or surface-modified. The maximum length assessed is 122 ± 43 nm. The opinion explicitly states it is “not applicable to any hydroxyapatite (nano) material that is composed of or contains needle-shaped particles.”

This specificity matters. A retail product that uses nano-HAp matching these specifications falls within the assessed safety envelope. A product that uses needle-shaped particles, coated particles, or particles outside the assessed size range is not covered by this opinion — even if the label says “nano-hydroxyapatite.” Most retail labels don’t disclose enough particle detail for a consumer to verify the match.

The SCCS also updated its position from earlier opinions. Its 2023 Submission III opinion had found nano-HAp safe at up to 10% in toothpaste and 0.465% in mouthwash. The 2025 opinion significantly raised both thresholds based on new submitted evidence — demonstrating that safety assessments evolve as data accumulates.

FDA Status and the ADA Seal Are Different Questions

FDA: In the US, toothpaste that claims to prevent cavities is regulated as an over-the-counter drug under the FDA’s monograph system (21 CFR Part 355). The recognized anticaries active ingredients are specific fluoride compounds (sodium fluoride, stannous fluoride, sodium monofluorophosphate) at specified concentrations. Hydroxyapatite is not listed as an approved anticaries active under this monograph.

This means HAp toothpaste in the US is marketed as a cosmetic product, not a drug. It can claim to “clean” or “whiten” teeth (cosmetic claims) but cannot legally claim to “prevent cavities” or “treat” a dental condition without drug approval. Some brands navigate this with careful language — “supports remineralization” rather than “prevents cavities” — but the regulatory line is clear: HAp is not an FDA-approved anticaries agent.

This is a regulatory-pathway distinction, not a safety finding. The FDA hasn’t evaluated and rejected HAp for safety concerns — it simply hasn’t approved it as a drug active through the monograph process. Manufacturers could pursue FDA approval through appropriate pathways, but none have done so to date.

ADA Seal: The ADA Seal of Acceptance is a voluntary program. Manufacturers submit their products along with clinical evidence, and the ADA’s Council on Scientific Affairs evaluates them. As of September 2026, no HAp-only toothpaste carries the Seal. This could mean manufacturers haven’t applied, that submitted evidence didn’t meet ADA criteria, or both — the ADA doesn’t publicly disclose application details.

The absence of the Seal is not evidence of harm. It is absence of this particular professional endorsement. Many safe, effective oral care products don’t carry the ADA Seal — it’s a quality signal, not a safety clearance.

Children, Pregnancy, Breastfeeding and Accidental Swallowing

Children: The Paszynska et al. (2021) trial studied children aged 2–6 using a microcrystalline HAp toothpaste over 12 months without reporting significant adverse events. The SCCS assessment addresses nano-HAp material safety generally. However, neither constitutes comprehensive pediatric safety data equivalent to what exists for fluoride in children. The ADA and AAPD provide specific fluoride dosing guidance by age. Comparable HAp-specific age guidance from a US professional body does not exist.

Parents considering HAp toothpaste for children should discuss the decision with their child’s dentist, particularly regarding the child’s individual caries risk and the relative strength of the evidence base compared to fluoride. For the detailed children’s guide, see: Hydroxyapatite Toothpaste for Kids.

Pregnancy and breastfeeding: No HAp-specific pregnancy or breastfeeding safety studies were identified in this review. The SCCS assessment addresses oral mucosa exposure and incidental ingestion in adults — it does not specifically evaluate gestational or lactational exposure. Pregnant and breastfeeding individuals should consult their healthcare provider before switching toothpaste ingredients, particularly if their current fluoride toothpaste was recommended by their dentist for caries management during pregnancy (a period of increased caries risk for some individuals).

Accidental swallowing: The SCCS opinion states that unintentionally ingested nano-HAp particles “undergo rapid dissolution in the gastric fluid and therefore do not raise any nano-specific concern over safety.” This addresses the material behavior in gastric conditions — it is not a finding that swallowing toothpaste is safe or recommended. All toothpaste, HAp or fluoride, is designed to be spit out after brushing. Young children who cannot reliably spit should use age-appropriate amounts under supervision, regardless of the active ingredient.

Other Ingredients, Allergies and Irritation

HAp is one ingredient in a toothpaste formula. The complete product also contains surfactants, flavoring, sweeteners, thickeners, preservatives and sometimes additional active ingredients (potassium nitrate for sensitivity, silica for abrasion). Safety or irritation reactions may come from any of these components, not just the hydroxyapatite.

If you experience mouth irritation, tingling, rash, or any unusual reaction after switching to an HAp toothpaste, stop using it and consult your dentist. The reaction may be to the HAp, to another ingredient (SLS, a flavor compound, a preservative), or to the change in formulation rather than any single ingredient. Your dentist can help identify the likely cause.

Check the full ingredient list, not just the headline marketing. “Natural” or “clean” labels on HAp toothpastes don’t mean the product is free of potential allergens or irritants — they mean the manufacturer has chosen to market with those terms.

When to Seek Professional Advice

Talk to your dentist before switching if you fall into any of these categories: active cavities or recent caries history (your dentist may specifically recommend fluoride); dry mouth or medications that reduce saliva; pregnancy or breastfeeding; immune-compromised status; young children (your pediatric dentist should weigh in); or any history of oral tissue reactions to dental products.

For healthy adults at low to moderate caries risk, the existing safety evidence is promising with respect to the studied formulations and exposures; however, it does not confirm the safety of all HAp products and populations. Whether it protects you as well as your current toothpaste depends on the specific product, your individual risk, and the strength of evidence you require before making the switch.

Frequently Asked Questions

Is HAp toothpaste FDA-approved?

Hydroxyapatite is not recognized as an anticaries active ingredient under the FDA’s OTC monograph. This means HAp toothpaste is marketed as a cosmetic product in the US, not a drug. It’s a regulatory-classification distinction, not a safety verdict. The FDA hasn’t evaluated and rejected HAp for safety reasons — it hasn’t approved it through the drug monograph process.

Does the lack of an ADA Seal prove HAp is harmful?

No. The ADA Seal is a voluntary professional endorsement. Many safe, effective products don’t carry it — either because manufacturers haven’t applied or because the submitted evidence didn’t meet ADA’s specific criteria. Absence of the Seal is absence of this endorsement, not evidence of harm.

Does the EU opinion apply to every nano-HAp product?

No. The SCCS opinion specifies particle characteristics: rod-shaped, uncoated, with defined aspect ratios and maximum length. Products using needle-shaped particles, coated particles, or particles outside the assessed specifications are not covered. Most retail labels don’t disclose enough particle detail for consumers to verify the match.

Can I safely swallow HAp toothpaste?

No toothpaste — HAp or fluoride — is designed to be swallowed. The SCCS found that incidentally ingested nano-HAp dissolves in gastric fluid without raising nano-specific safety concerns. That’s a reassuring finding about accidental exposure, not a recommendation that swallowing is safe or intended. Spit and rinse after brushing.

Is HAp toothpaste safe during pregnancy?

No HAp-specific pregnancy studies were identified. The EU assessment addresses adult oral use, not gestational exposure specifically. Pregnant individuals should discuss toothpaste choices with their healthcare provider, particularly if fluoride toothpaste was recommended for caries management during pregnancy.

Is nano-HAp dangerous?

The EU SCCS found no mutagenic hazard, cytotoxicity, or inflammatory effects for the specified nano-HAp particles at assessed concentrations. The word “nano” triggers concern for some consumers, but the safety assessment specifically addressed nanoparticle behavior — including that ingested particles dissolve in gastric fluid. The concern is more about undefined or unspecified nano particles than about the category as a whole.

Get the Free Oral Health Guide

Download Beyond Brushing — a practical 30,000+ word guide to healthier teeth, gums, and fresher breath after 45.

Please enable JavaScript in your browser to complete this form.

Marketing Email consent

Email *

Marketing email consent *

• Please check here to join our email list.

Send Me the Free Guide

• No spam • Unsubscribe anytime